Clinical application of functional glycoproteomics–dissection of glycotopes carried by soluble CD44 variants in sera of patients with cancers

KT Lim, K Miyazaki, N Kimura, M Izawa… - Proteomics, 2008 - Wiley Online Library
We provide here an example of clinical application of functional glycoproteomics for cancer
diagnosis. Sialyl Lewis a and sialyl Lewis x glycotopes, which are the specific ligands for …

[HTML][HTML] CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications

R Azevedo, C Gaiteiro, A Peixoto, M Relvas-Santos… - Clinical proteomics, 2018 - Springer
CD44 is a heavily glycosylated membrane receptor playing a key role in cell adhesion,
signal transduction and cytoskeleton remodelling. It is also one of the most studied …

Aberrant glycosylation as biomarker for cancer: focus on CD43

FM Tuccillo, A de Laurentiis, C Palmieri… - BioMed research …, 2014 - Wiley Online Library
Glycosylation is a posttranslational modification of proteins playing a major role in cell
signalling, immune recognition, and cell‐cell interaction because of their glycan branches …

[HTML][HTML] Impact of Truncated O-glycans in Gastric-Cancer-Associated CD44v9 Detection

IB Moreira, F Pinto, C Gomes, D Campos, CA Reis - Cells, 2020 - mdpi.com
CD44 variant isoforms are often upregulated in cancer and associated with increased
aggressive tumor phenotypes. The CD44v9 is one of the major protein splice variant …

Evaluation of soluble CD44v6 as a potential serum marker for head and neck squamous cell carcinoma

NLW Van Hal, GAMS Van Dongen, CBM Ten Brink… - Clinical cancer …, 1999 - AACR
In recent years, the measurement of soluble CD44 levels in the circulation of patients with
malignant diseases has been introduced as a new and simple diagnostic tool for the …

Development of a sandwich enzyme-linked immunosorbent assay for the detection of CD44v3 using exon v3-and v6-specific monoclonal antibody pairs

MH Jeoung, TK Kim, H Shim, S Lee - Journal of Immunological Methods, 2016 - Elsevier
It has been suggested that soluble CD44 levels in cancer patient sera may be closely
associated with tumor progression and metastasis. However, to date, there has been limited …

Expression of CD44 isoforms and β1, 6‐branched oligosaccharides in human malignant melanoma is correlated with tumor progression but not with mettastatisc …

WKF Seelentag, R Böni, U Günthet… - Journal of cutaneous …, 1997 - Wiley Online Library
CD44, a family of closely related glycoproteins generated by alternative splicing, as well as
the increased β1, 6‐branching of Asn‐linked oligosaccharides (β1, 6‐branches), have been …

Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer

G Sliutz, C Tempfer, S Winkler, P Kohlberger… - British journal of …, 1995 - nature.com
The surface glycoprotein CD44 is widely distributed in different tissues. In contrast to healthy
tissue, tumour samples show a more complex pattern of CD44 expression, indicating a loss …

The serum assay of soluble CD44 standard, CD44 variant 5, and CD44 variant 6 in patients with gastric cancer

CH Yoo, SH Noh - Cancer Research and Treatment, 2003 - e-crt.org
PURPOSE: Alternative splicing of CD44 and aberrant levels of soluble CD44 (sCD44)
protein in the serum of cancer patients has been correlated to tumor progression and …

Significant elevation of tumour-associated isoforms of soluble CD44 in serum of normal individuals caused by cigarette smoking

EM Kittl, R Ruckser, I Rech-Weichselbraun… - 1997 - degruyter.com
While performing a prospective study on sCD44 variant isoforms as tumour markers in
certain malignancies, we detected relevant differences in the control group between non …